One experimental drug that has been developed may be the answer for patients affected by inflammatory bowel disease that have been unresponsive to current medications. The drug is known as vedolizumab and is being developed to treat two forms of IBD – ulcerative colitis and Crohn’s Disease.
Both of these diseases occur in the digestive tract and can lead to chronic inflammation, abdominal cramps, diarrhea, and rectal bleeding. During new trials, researchers have discovered that vedolizumab had succeeded in cases where standard medications have been ineffective.
The drug was reported to be more effective for colitis than for Crohn’s. The drug may receive FDA approval for the treatment of colitis first. This is a potential new solution for the 2,000 patients that have either colitis or Crohn’s and have failed to see improvements from standard medications.
During a single trial, 47 percent of a group of 900 colitis patients given vedolizumab infusions reported a decrease in symptoms.
Struggling with constant bloating, acid reflux, or stomach pain? 🚨 It’s NOT something you should ignore. Your gut health affects everything—from your energy levels to your immune system. At BH Center for Digestive Health, we focus on identifying the root cause, not...
April is Oral Cancer Awareness Month — but here’s what most people don’t realize: Your oral health is directly connected to your digestive system. Persistent sores, difficulty swallowing, or unusual lumps aren’t just dental concerns — they can signal deeper...
Struggling with bloating, acid reflux, or stomach pain... but ignoring it? Here’s the truth 👇Your gut is NOT supposed to feel uncomfortable every day. Most people normalize symptoms like:• Frequent bloating• Heartburn after meals• Irregular digestion But these are...
(310) 855-0222
Fax: (949) 404-6467
Mon - Fri: 9am – 5pm
Sat - Sun: Closed